Peptide Profiles

Gastric pentadecapeptide studied mostly in rodent tendon and gut healing models.

$18 – $32 median · 5mg

Thymosin beta-4 fragment examined in preclinical wound and cardiac repair work.

$24 – $39 median · 5mg

GLP-1 receptor agonist with a large human clinical trial record in metabolic research.

$54 – $96 median · 5mg

Dual GIP/GLP-1 agonist studied in large randomized metabolic endpoints.

$79 – $128 median · 10mg

Selective growth hormone secretagogue with limited but consistent early human data.

$15 – $28 median · 5mg

GHRH analogue often paired with secretagogues in pulsatile release research.

$19 – $34 median · 2mg

Copper tripeptide with dermal remodeling data from in vitro and topical studies.

$26 – $42 median · 50mg

Tetrapeptide investigated in small telomerase and circadian studies, largely single-group.

$27 – $45 median · 10mg

Coenzyme studied for mitochondrial and cellular energy endpoints; delivery is contested.

$49 – $78 median · 500mg

Melanocortin agonist with completed randomized human trials on arousal endpoints.

$22 – $36 median · 10mg

Anxiolytic peptide with mostly Russian-language clinical literature.

$20 – $31 median · 10mg

Triple agonist with phase 2 metabolic results published and phase 3 ongoing.

$98 – $152 median · 10mg

Myostatin protein studied for its role in limiting skeletal muscle growth.

$75 – $106 median · 1mg

Spadin analogue studied in rodent models of depression via TREK-1 channel blockade.

$35 – $50 median · 10mg

Potent growth hormone secretagogue with a comparatively old human research record.

$28 – $40 median · 5mg

PEGylated mechano growth factor splice variant studied in muscle repair models.

$25 – $35 median · 2mg

Human menopausal gonadotropin, a long-established gonadotropin preparation studied in fertility research.

$35 – $50 median · 75IU

Adamantane-modified nootropic peptide with very little published data.

$30 – $43 median · 5mg

Growth hormone releasing peptide with reproducible secretagogue data in animal and early human work.

$21 – $30 median · 10mg

Early-generation growth hormone releasing peptide with a well-documented appetite signal.

$18 – $25 median · 5mg

Human chorionic gonadotropin, a heavily studied glycoprotein hormone supplied for laboratory research.

$30 – $43 median · 5000IU

Multi-component blend combining KPV, LL-37, GHK-Cu and BPC-157 in one vial.

$105 – $149 median · 80mg

GLP-1 and glucagon dual agonist with published phase 2 metabolic and liver outcomes.

$50 – $71 median · 10mg

Small-molecule NNMT inhibitor studied in adipocyte and metabolic models.

$45 – $64 median · 10mg

Immunomodulatory peptide approved as a medicine in several countries and widely studied in infection research.

$35 – $50 median · 10mg

First-generation GLP-1 agonist with a large clinical trial literature behind it.

$70 – $99 median · 10mg

Short synthetic tripeptide from the Khavinson bioregulator series, studied in Russian-language neuroprotection work.

$30 – $42 median · 10mg

Palmitoyl pentapeptide studied in topical collagen and dermal matrix research.

$25 – $35 median · 10mg

Senolytic peptide studied for selectively clearing senescent cells in animal models.

$170 – $241 median · 10mg

Vasoactive intestinal peptide, an endogenous neuropeptide with a broad research literature.

$45 – $64 median · 10mg

Lipotropic compounded solution of methionine, inositol, choline and B vitamins.

$45 – $64 median · 10ml

Mitochondria-targeted tetrapeptide, also known as elamipretide, with clinical trial data.

$50 – $71 median · 10mg

Mitochondrial-derived peptide studied in cytoprotection and metabolic ageing research.

$90 – $128 median · 10mg

Endogenous tripeptide antioxidant with an extensive biochemical literature.

$45 – $64 median · 1500mg

Synthetic GnRH decapeptide with a long clinical and diagnostic research record.

$40 – $57 median · 5mg

Recombinant erythropoietin, a glycoprotein hormone with a large clinical literature.

$100 – $142 median · 3000IU

Khavinson immune bioregulator tetrapeptide with a narrow published record.

$60 – $85 median · 20mg

Khavinson bioregulator peptide studied in peripheral nerve and cortical tissue models.

$45 – $64 median · 20mg

Cardiac-tissue bioregulator peptide from the Khavinson series.

$55 – $78 median · 20mg

Single-chain relaxin analogue studied for anti-fibrotic signalling.

$35 – $50 median · 10mg

Soluble activin receptor fusion protein studied as a myostatin pathway inhibitor.

$45 – $64 median · 1mg

Full-length adrenocorticotropic hormone with a deep endocrine research literature.

$50 – $71 median · 5mg

GHRH analogue approved as a medicine for HIV-associated lipodystrophy, with phase 3 data.

$65 – $92 median · 5mg

Erythropoietin-derived 11-mer studied in small neuropathy trials.

$55 – $78 median · 10mg

GHRH 1-29 fragment with a long clinical history in growth hormone diagnostics.

$35 – $50 median · 5mg

Growth hormone fragment 176-191 studied for lipolytic activity, with human trial data.

$44 – $62 median · 5mg

GLP-1 and glucagon dual agonist based on oxyntomodulin, with phase 3 data in China.

$65 – $92 median · 10mg

Amphibian-derived opioid heptapeptide studied in receptor pharmacology research.

$29 – $41 median · 5mg

Acetyl octapeptide studied in topical expression-line cosmetic research.

$20 – $28 median · 10mg

Alpha-MSH tripeptide fragment studied for anti-inflammatory activity in gut models.

$25 – $35 median · 5mg

Human cathelicidin antimicrobial peptide with a substantial immunology literature.

$30 – $43 median · 5mg

Long-acting IGF-1 analogue with reduced binding-protein affinity.

$35 – $50 median · 1mg

Thymic peptide extract studied in Russian immune-ageing research.

$25 – $35 median · 10mg

Upstream regulator of GnRH release with a growing human research literature.

$25 – $35 median · 5mg

Delta sleep-inducing peptide with an old and inconsistent research record.

$25 – $35 median · 5mg

Combination vial pairing GHK-Cu, BPC-157 and TB-500 for skin and repair research.

$90 – $128 median · 70mg

ACTH 4-10 analogue registered as a medicine in Russia and studied in stroke research.

$25 – $35 median · 5mg

Mitochondrial-derived peptide studied in exercise metabolism and insulin sensitivity models.

$25 – $35 median · 10mg

Nonapeptide hormone with an enormous clinical and behavioural research literature.

$30 – $42 median · 10mg